A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer's disease
Cholinesterase (ChE) enzymes have been identified as diagnostic markers for Alzheimer disease (AD). Substrate-based probes have been synthesised to detect ChEs but they have not detected changes in ChE distribution associated with AD pathology. Probes are typically screened using spectrophotometric...
Saved in:
Main Authors: | Sultan Darvesh (Author), Scott Banfield (Author), Maeve Dufour (Author), Katrina L. Forrestall (Author), Hillary Maillet (Author), G. Andrew Reid (Author), Dane Sands (Author), Ian R. Pottie (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolism of six CYP probe substrates in fetal hepatocytes
by: Abdul Naveed Shaik, et al.
Published: (2016) -
Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
by: Jae-Kyung Heo, et al.
Published: (2018) -
Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer's Disease
by: Ignazio Schino, et al.
Published: (2022) -
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels
by: Marion Ortner, et al.
Published: (2020) -
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease
by: Yao Chen, et al.
Published: (2018)